Javascript must be enabled to continue!
The International Classification of Diseases, 10 th Edition, Clinical Modification (ICD-10-CM) Code I16.0 Accurately Identifies Patients wi
View through CrossRef
ABSTRACT
Objective
Hypertensive urgency, defined as acutely elevated BP without target organ damage, is associated with an increased risk of adverse cardiovascular events and accounts for a substantial proportion of national emergency department (ED) visits. To advance research in this space, we sought to validate the new
ICD-10-CM
diagnostic code for hypertensive urgency within a single healthcare system.
Methods
We performed a retrospective chart-review study of ED encounters at Weill Cornell Medicine from 2016 – 2021. We randomly selected 25 encounters with the
ICD-10-CM
code I16.0 as the primary discharge diagnosis and 25 encounters with primary
ICD-10-CM
discharge diagnosis codes for benign headache disorders. A single board-certified vascular neurologist reviewed all 50 encounters while blinded to the assigned
ICD-10-CM
codes to identify cases of hypertensive urgency. We calculated the sensitivity, specificity, and positive predictive values of the
ICD-10-CM
code I16.0 with 95% confidence intervals (CI).
Results
Out of 50 randomly selected ED encounters, 24 were adjudicated as hypertensive urgency. All encounters adjudicated as hypertensive urgency had been assigned the
ICD-10-CM
discharge diagnosis code of I16.0. All 25 of the encounters adjudicated as headache were assigned an
ICD-10-CM
discharge diagnosis code for a benign headache disorder. The
ICD-10-CM
code for hypertensive urgency, I16.0, was thus found to have a sensitivity of 100% (95% CI: 86-100%), specificity of 96% (95% CI: 80-100%), and positive predictive value of 96% (95% CI: 78-99%).
Conclusion
We found that the new
ICD-10-CM
code for hypertensive urgency, I16.0, can reliably identify patients with this condition.
Title: The
International Classification of Diseases, 10
th
Edition, Clinical Modification (ICD-10-CM)
Code I16.0 Accurately Identifies Patients wi
Description:
ABSTRACT
Objective
Hypertensive urgency, defined as acutely elevated BP without target organ damage, is associated with an increased risk of adverse cardiovascular events and accounts for a substantial proportion of national emergency department (ED) visits.
To advance research in this space, we sought to validate the new
ICD-10-CM
diagnostic code for hypertensive urgency within a single healthcare system.
Methods
We performed a retrospective chart-review study of ED encounters at Weill Cornell Medicine from 2016 – 2021.
We randomly selected 25 encounters with the
ICD-10-CM
code I16.
0 as the primary discharge diagnosis and 25 encounters with primary
ICD-10-CM
discharge diagnosis codes for benign headache disorders.
A single board-certified vascular neurologist reviewed all 50 encounters while blinded to the assigned
ICD-10-CM
codes to identify cases of hypertensive urgency.
We calculated the sensitivity, specificity, and positive predictive values of the
ICD-10-CM
code I16.
0 with 95% confidence intervals (CI).
Results
Out of 50 randomly selected ED encounters, 24 were adjudicated as hypertensive urgency.
All encounters adjudicated as hypertensive urgency had been assigned the
ICD-10-CM
discharge diagnosis code of I16.
All 25 of the encounters adjudicated as headache were assigned an
ICD-10-CM
discharge diagnosis code for a benign headache disorder.
The
ICD-10-CM
code for hypertensive urgency, I16.
0, was thus found to have a sensitivity of 100% (95% CI: 86-100%), specificity of 96% (95% CI: 80-100%), and positive predictive value of 96% (95% CI: 78-99%).
Conclusion
We found that the new
ICD-10-CM
code for hypertensive urgency, I16.
0, can reliably identify patients with this condition.
Related Results
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry
IntroductionSubcutaneous ICD (S-ICD) is an alternative to a transvenous implantable cardioverter-defibrillator (TV-ICD) system in selected patients not in need of pacing or resynch...
The Effect of Clinical Knee Measurement in Children with Genu Varus
The Effect of Clinical Knee Measurement in Children with Genu Varus
Abstract
Introduction
Children with genu varus needs frequent assessment and follow up that may need several radiographies. This study investigates the effectiveness of the clinica...
Phecoder: semantic retrieval for auditing and expanding ICD-based phenotypes in EHR biobanks
Phecoder: semantic retrieval for auditing and expanding ICD-based phenotypes in EHR biobanks
Abstract
Background
Electronic health record (EHR)–based phenotyping underpins genome-wide association studies, yet current ICD...
Benefit of Implantable Cardioverter Defibrillator Use in Japanese Patients Based on Modified MADIT-ICD Benefit Score
Benefit of Implantable Cardioverter Defibrillator Use in Japanese Patients Based on Modified MADIT-ICD Benefit Score
Abstract
Aims
The MADIT-ICD benefit score is used to stratify the risk of life-threatening arrhythmia and non-arrhythmic ...
Arrythmic storm in patients with and without an implantable cardioverter defibrillator
Arrythmic storm in patients with and without an implantable cardioverter defibrillator
Abstract
Introduction
Available data on arrhythmic storm (AS) is frequently obtained from retrospective observational series of ...
Impact of Cardiac Resynchronization Therapy on Hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial
Impact of Cardiac Resynchronization Therapy on Hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial
Background—
This study reports the impact of cardiac resynchronization therapy (CRT) on hospitalizations in patients randomized to implantable cardioverter-defi...
Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
BackgroundThe subcutaneous implantable cardioverter-defibrillator (S-ICD) has been designed to overcome lead-related complications and device endocarditis. Lacking the ability for ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

